Vijay Modur
2021
In 2021, Vijay Modur earned a total compensation of $3.3M as Head of Research and Development at Sevion Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $212,500 |
|---|---|
| Option Awards | $2,005,683 |
| Salary | $326,923 |
| Stock Awards | $736,935 |
| Total | $3,282,041 |
Modur received $2M in option awards, accounting for 61% of the total pay in 2021.
Modur also received $212.5K in non-equity incentive plan, $326.9K in salary and $736.9K in stock awards.
Rankings
In 2021, Vijay Modur's compensation ranked 4,079th out of 12,415 executives tracked by ExecPay. In other words, Modur earned more than 67.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,079 out of 12,415 | 67th |
Division Manufacturing | 1,681 out of 5,501 | 69th |
Major group Chemicals And Allied Products | 694 out of 2,371 | 71st |
Industry group Drugs | 617 out of 2,092 | 71st |
Industry Biological Products, Except Diagnostic Substances | 162 out of 449 | 64th |
Source: SEC filing on April 28, 2023.
Modur's colleagues
We found two more compensation records of executives who worked with Vijay Modur at Sevion Therapeutics in 2021.